Andrew Hirsch Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Hirsch.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Hirsch. Andrew Hirsch is a COO and CFO in BIND Therapeutics, Inc ($BIND) and a PRESIDENT & CEO in BIND Therapeutics, Inc ($BIND) and a Chief Financial Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Editas Medicine, Inc. ($EDIT) and a See Remarks in C4 Therapeutics, Inc. ($CCCC).
Address: C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE 02139 MA
Companies in which Andrew Hirsch is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Hirsch: Chief Financial Officer
Holdings: 26,199 shares
Current Value: $1,163,760
Latest Transaction: Apr 24 2020
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
C4 Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew Hirsch: See Remarks
Holdings: 0 shares
Latest Transaction: Oct 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DNIB UNWIND, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Hirsch: PRESIDENT & CEO, COO and CFO
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew Hirsch: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2020
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew Hirsch
Sentiment: All, AGIO, CCCC, BIND, EDIT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Hirsch Andrew | See Remarks | Option Exercise | A | 19.00 | 1,691,672 | 32,141,768 | 1,691,672 | |
| Jun 12 2020 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
| Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,893 | 0 | 11,785 | |
| Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 45.91 | 1,927 | 88,469 | 24,272 | 26.2 K to 24.3 K (-7.36 %) |
| Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 5,893 | 0 | 26,199 | 20.3 K to 26.2 K (+29.02 %) |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,387 | 0 | 10,775 | |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 40.64 | 1,599 | 64,983 | 20,306 | 21.9 K to 20.3 K (-7.30 %) |